Gastric vs Transpyloric Feeding for Bronchopulmonary Dysplasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two feeding methods to determine which is best for infants with severe bronchopulmonary dysplasia (BPD), a lung condition, who also struggle with feeding. Infants will try both gastric feeding (feeding into the stomach) and transpyloric feeding (feeding past the stomach into the small intestine) for a few weeks each. The trial aims to assess how each method affects the infants' breathing. Babies born before 32 weeks and showing feeding issues like reflux or chronic aspiration may be suitable candidates. As an unphased trial, this study provides a unique opportunity to enhance understanding and improve feeding methods for vulnerable infants.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study showed that feeding infants with bronchopulmonary dysplasia (BPD) through the stomach is a promising treatment option. Many infants tolerated it well, and fewer required more invasive feeding methods. However, more studies are needed to confirm its overall safety for infants with BPD.
Conversely, research has shown that feeding through a tube placed into the small intestine, known as transpyloric feeding, has been linked to negative outcomes in the hospital for infants with severe BPD. These findings raise concerns about its safety for these infants.
In summary, while stomach feeding appears to be better tolerated, feeding through the small intestine may pose risks for infants with severe BPD. Further research is necessary to fully understand the safety of both feeding methods.12345Why are researchers excited about this trial?
Unlike traditional feeding methods for bronchopulmonary dysplasia, which typically involve gastric feeding, transpyloric feeding offers a unique approach by delivering nutrition directly to the small intestine. This method can potentially reduce the risk of aspiration and improve nutrient absorption, which is crucial for infants with this condition. Researchers are excited about comparing these two feeding methods because they aim to determine which method provides better respiratory outcomes and overall growth in these vulnerable patients.
What evidence suggests that this trial's feeding methods could be effective for bronchopulmonary dysplasia?
This trial will compare gastric feeding with transpyloric feeding for infants with severe bronchopulmonary dysplasia (BPD). Studies have shown that feeding infants directly into the stomach can sometimes cause lower oxygen levels in the blood, known as hypoxemia. Despite this, it is often used when infants require tube feeding into the stomach. Alternatively, transpyloric feeding, which involves feeding through a tube that bypasses the stomach and enters the small intestine, has been associated with fewer breathing issues and less frequent pauses in breathing and slow heart rate. Some research suggests that starting transpyloric feeding early may reduce the risk of death or BPD and decrease the need for breathing machines. Each feeding method has its advantages, and this trial aims to determine the best approach based on the infant's specific needs.16789
Who Is on the Research Team?
Mark Weems, MD
Principal Investigator
University of Tennessee
Are You a Good Fit for This Trial?
This trial is for hospitalized infants with severe bronchopulmonary dysplasia (BPD) who are experiencing feeding intolerance. The study requires a crossover, meaning each infant will try both feeding methods for two weeks each.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to 2 weeks of continuous gastric feeding or continuous transpyloric feeding, followed by a crossover to the other feeding mode for an additional 4 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Gastric feeding
- Transpyloric feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
Le Bonheur Children's Hospital
Lead Sponsor